Cure GM1 Held an INTERACT Meeting About ERT with The FDA
Cure GM1 Moves ERT One Step Closer to A Trial We have some incredible news…
-
-
Cure GM1 Allocates Up to $1.4 Million to Advance Enzyme Replacement Therapy
Cure GM1 is dedicated to investing in research and to the development of multiple treatment…
-
-
2025 Cure GM1 Impact Report
All we’ve Achieved in 2025 THANK YOU. With your help, the Cure GM1 Foundation had…
-
-
-
GM1 Research: Cure GM1 Invests $400,000 to Advance Development of Enzyme Replacement Therapy
Cure GM1 is dedicated to investing in research, seeding new projects, and to the development of multiple treatment modalities for GM1 gangliosidosis. In collaboration with our advisors and consultants, who have decades of experience in biotech and research, Cure GM1 has selected a contract research organization (CRO) to further the development of enzyme replacement therapy (ERT).
-
2024 Cure GM1 Impact Report
Our summary of impact in 2024 is now available to read. Although this year was hard with…
-
2023 Cure GM1 Impact Report – Annual Update And Beyond
Our summary of impact in 2023 is now available to read. After some time reflecting, everyone…
